QCM
RMD icon

Qsemble Capital Management’s ResMed RMD Stock Holding History

Qsemble Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,984
Closed -$728K – 513
2024
Q3 		$728K Buy
+2,984
New +$667K 0.13% 221
2023
Q3 		– Sell
-6,650
Closed -$1.45M – 399
2023
Q2 		$1.45M Buy
+6,650
New +$1.48M 1.03% 22
2023
Q1 		– Sell
-7,600
Closed -$1.58M – 320
2022
Q4 		$1.58M Buy
+7,600
New +$1.67M 1.1% 23

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Qsemble Capital Management's RMD Position: Q4 2024 in Review

Qsemble Capital Management sold out of ResMed (RMD) in Q4 2024, closing a stake of 2,984 shares — an estimated $728K sold.

Qsemble Capital Management first reported a position in RMD in Q4 2022 and held it in 3 quarters. The position peaked at $1.58M in Q4 2022. 871 funds tracked by Wall St. Rank hold RMD as of Q4 2024.

  • Qsemble Capital Management reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
  • Qsemble Capital Management sold 2,984 ResMed shares in Q4 2024, an estimated $728K.
  • Qsemble Capital Management first reported a position in ResMed in Q4 2022 and held it in 3 quarters.
  • Qsemble Capital Management's ResMed position peaked at $1.58M in Q4 2022.
  • 871 funds tracked by Wall St. Rank held ResMed as of Q4 2024.

Based on Qsemble Capital Management's 13F filing for Q4 2024, filed 11 Feb 2025.